New Data-sharing Program Aims to Speed Innovation in Rare Diseases
A new U.S. initiative called Rare Disease Cures Accelerator–Data and Analytics Platform — dubbed RDCA–DAP — aims to accelerate…
Bionews, the owner and publisher of this site, employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, who ensure stories are well-written and easy to understand. Our stories undergo a comprehensive fact-checking and editing process to confirm accuracy, objectiveness, and thoroughness in order to best serve our audience of patients and caregivers.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
A new U.S. initiative called Rare Disease Cures Accelerator–Data and Analytics Platform — dubbed RDCA–DAP — aims to accelerate…
A newly launched non-profit institute is seeking to advance research, and the development of new therapies, for people with rare…
Participation in clinical trials exposes rare disease patients to financial, physical, and emotional pressures, according to the results of a…
Photo courtesy of Ben Mattlin Day 31 of 31 This is Ben Mattlin’s (@benmattlin) story: The disability rights…
The National Organization for Rare Disorders, known as NORD, was named an official charity partner of the 2021 TCS…
Photo courtesy of Melissa Milinovich Day 30 of 31 This is Claudia Milinovich’s story: My mom is a normal…
Photo courtesy of Keith Schaper Day 29 of 31 This is Keith Schaper’s story: Our son, Oliver, was officially…
Photo courtesy of Autumn Day 28 of 31 This is Autumn’s (@itsss.autumn.here) story: Hi! I’m Autumn. I was…
Photo courtesy of Rachel O’Hagan Day 27 of 31 This is Rachel O’Hagan’s (@bravelikebeau) story: I am a…
Photo courtesy of Carissa Decelles Day 26 of 31 This is Carissa Decelles’ (@rheelgirl) story: Hello! My name…
Get regular updates to your inbox.